Fresenius Medical Care AG (NYSE:FMS) Short Interest Update

Fresenius Medical Care AG (NYSE:FMS) saw a large drop in short interest in August. As of August 15th, there was short interest totalling 632,800 shares, a drop of 26.0% from the July 31st total of 855,500 shares. Based on an average trading volume of 333,000 shares, the short-interest ratio is presently 1.9 days.

Fresenius Medical Care Trading Down 0.3 %

Fresenius Medical Care stock opened at $19.37 on Friday. Fresenius Medical Care has a 1 year low of $16.37 and a 1 year high of $24.48. The firm’s 50-day moving average is $19.30 and its 200-day moving average is $19.91. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.14 and a current ratio of 1.46. The company has a market cap of $11.37 billion, a P/E ratio of 21.75, a PEG ratio of 1.01 and a beta of 0.90.

Fresenius Medical Care (NYSE:FMS) last issued its earnings results on Tuesday, July 30th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.38. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.28 billion. Fresenius Medical Care had a net margin of 2.72% and a return on equity of 5.48%. On average, equities analysts expect that Fresenius Medical Care will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its holdings in shares of Fresenius Medical Care by 21.8% during the first quarter. GAMMA Investing LLC now owns 4,230 shares of the company’s stock valued at $82,000 after acquiring an additional 758 shares during the period. Assetmark Inc. boosted its stake in Fresenius Medical Care by 169.9% during the 4th quarter. Assetmark Inc. now owns 4,178 shares of the company’s stock valued at $87,000 after purchasing an additional 2,630 shares during the period. ORG Partners LLC bought a new position in Fresenius Medical Care in the 1st quarter worth about $110,000. SageView Advisory Group LLC acquired a new stake in shares of Fresenius Medical Care in the first quarter valued at approximately $127,000. Finally, Signaturefd LLC raised its holdings in shares of Fresenius Medical Care by 8.4% during the second quarter. Signaturefd LLC now owns 8,713 shares of the company’s stock valued at $166,000 after buying an additional 672 shares during the last quarter. Institutional investors and hedge funds own 8.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on FMS. Truist Financial cut their target price on shares of Fresenius Medical Care from $24.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday, July 31st. StockNews.com initiated coverage on Fresenius Medical Care in a research note on Thursday. They set a “strong-buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $22.00.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.